Medical News
Latest News on Primary Aldosteronism
- Cracking the Code: A Case Report on Low-Renin Hypertension July 25, 2024Low-renin hypertension (LRH) is characterized by hypertension accompanied by low serum renin levels. LRH is a spectrum, including low-renin essential hypertension (LREH), primary hyperaldosteron...cureusinc
- Setting New PACE For Hypertension July 19, 2024Some quick mathematics paints a disturbing pictureSix million Australians - one in three adults – have hypertension 1.3 billion people worldwide, oneMirage News
- Renal Stones and Primary Aldosteronism July 18, 2024There are few data describing the association between primary aldosteronism (PA) and nephrolithiasis. The reason for recurrent calcium nephrolithiasis may be related to the ...Docwire News
- Hudson Institute Probes High Blood Pressure, Heart Disease Causes July 12, 2024Hudson Institute is a key player in an exciting new primary aldosteronism (PA) project investigating the causes of PA, a common and potentiallyMirage News
- Renin Activity Test for Hypertension July 1, 2024Learn when your doctor might test this kidney enzyme and how the results could impact your treatment.Marygrace Taylor
- Eckert & Ziegler Subsidiary Pentixapharm Receives Encouraging FDA Feedback to Initiate Phase III Trial with PentixaFor as Radiopharmaceutical Diagnostic in Primary Aldosteronism June 25, 2024WÜRZBURG, Germany, June 25, 2024 (GLOBE NEWSWIRE) -- Pentixapharm AG, a radiopharmaceutical development company wholly owned by Eckert & Ziegler...Pentixapharm AG
- Urinary chloride-to-potassium ratio as a potential novel index for MR activity in patients with hypertension June 24, 2024Hypertension Research - Urinary chloride-to-potassium ratio as a potential novel index for MR activity in patients with hypertensionNature
PA Foundation in the News
- Primary Aldosteronism AllianceIn September 2022, the PA Foundation announced the creation of a multistakeholder alliance to drive diagnosis and treatment of primary aldosteronism.
- Dietary Sodium Global Call to ActionThe PA Foundation is one of the co-authors of the World Hypertension League’s call to action published in May 2022 by the Journal of Human Hypertension.
- BMJ Practice Series: Easily Missed?The PA Foundation co-authored the article of the BMJ Practice Series on primary aldosteronism. The open access article was published in April 2022.
- Doctors Overlook a Curable Cause of High BPMIT’s magazine, Undark, featured the PA Foundation in an article of its February 2022 edition dedicated to primary aldosteronism.
Notable Publications of the Year
Primary Aldosteronism in the EROver 40% of patients presenting to the ER of an Australian tertiary health network met the criteria for PA testing. Only 2% were screened.
BPA and Primary Aldosteronism ScreeningImplementation of an EHR best-practice advisory yielded a screening rate of 14%. Most orders were placed by internists (40%) and primary care physicians (28%).
AVS and Asymmetrical Bilateral PAMultifocal, asymmetrical bilateral PA cannot be excluded by robust AVS lateralization. The study’s independent predictors of postoperative residual PA included Black race, AVS lateralization only at baseline, and CT-AVS disagreement.
68Ga-Pentixafor PET/CT and Subtyping of PAIn a study of 123 patients with adrenal micronodules, the sensitivity, specificity, and accuracy of 68Ga-pentixafor PET/CT in subtyping primary aldosteronism were 90.2%, 86.3%, and 89.4%, respectively. The accuracy of AVS examination was lower than that of PET/CT.
Latest News on Hypertension
- Facts About High Blood Pressure July 26, 2024What is hypertension or high blood pressure? High blood pressure, also known as HBP or hypertension, is when your blood pressure, the force of the blood flowing through your blood vessels, is consistently too high.www.heart.org
- Consensus statement on renal denervation by the Joint Committee of Japanese Society of Hypertension (JSH), Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT), and the Japanese Circulation Society (JCS) July 26, 2024Hypertension Research - Consensus statement on renal denervation by the Joint Committee of Japanese Society of Hypertension (JSH), Japanese Association of Cardiovascular Intervention and...Nature
- Vasculopathy Varies in Idiopathic Pulmonary Arterial Hypertension July 26, 2024Diffusion capacity of the lungs for carbon monoxide was a distinguishing factor in a new study.Heidi Splete
- How the brain responds to sleep apnea July 25, 2024Researchers have discovered underlying mechanisms within the brain that contribute to high blood pressure for people with sleep apnea.Futurity
- Study confirms esaxerenone as a safe and effective alternative for hypertension treatment July 25, 2024Researchers find that esaxerenone is a non-inferior alternative to trichlormethiazide for treating uncontrolled hypertension in Japanese patients. The study confirms similar safety profiles for both drugs.News-Medical
- SoniVie Reports Major Advancements in Renal Denervation Program for Hypertension: REDUCED-1 Results, First-In-Human Data, FDA’s Crucial IDE Approval of Global THRIVE study July 25, 2024SoniVie's major advancements in renal denervation for hypertension: REDUCED-1 results, First-In-Human data, FDA’s crucial IDE approval.GeneOnline News